In honor of Pride Month, the Columbia Gender & Sexuality Program (CGSP) offers a family-friendly guide to support LGBTQIA+ youth and caregivers and to events taking place across the city.
A study led by Matisyahu Shulman, MD, found that rapid administration of extended-release naltrexone was effective compared with the standard procedure used in the treatment of opioid use disorder.
The Times looks back at the life and accomplishments of Dr. Herbert Pardes (1934 to 2024), former Chair of our department and Executive Director of the New York State Psychiatric Institute.
Paul Appelbaum, MD, says that it may be time to rethink standards for involuntary commitment without necessarily returning to the low bar that existed decades ago.
Meg Haney, PhD, professor of neurobiology (in psychiatry), says that the recently announced reclassification of cannabis will eliminate some of the biggest hurdles to expanded clinical research.
Zachary Blumkin, PsyD, pushes back on the idea that widespread discussion of mental health can cause young people to assume even mild suffering is a sign of a disorder.
David Hellerstein, MD, a professor of clinical psychiatry, notes that patients who come off antidepressants too quickly can experience “brain zaps” and other side effects.
Dr. Pardes, noted psychiatrist and leader at Columbia University, the New York State Psychiatric Institute, and New-York Presbyterian, passed away April 30, 2024. He was 89.
